1 | ONCOTN0 ;Hines OIFO/GWB - AUTOMATIC STAGING ;6/11/93
|
---|
2 | ;;2.11;ONCOLOGY;**1,15,28,35**;Mar 07, 1995
|
---|
3 | ;
|
---|
4 | PART2 ;HEAD AND NECK SITES
|
---|
5 | ;
|
---|
6 | 3 ;Lip and Oral Cavity
|
---|
7 | D @$S(ONCOED=6:"LIP6^ONCSG0",ONCOED=5:"LIP5^ONCSG0",ONCOED>2:"LIP34^ONCSG0",1:"LIP12^ONCSG0")
|
---|
8 | Q
|
---|
9 | ;
|
---|
10 | 4 ;Pharynx
|
---|
11 | D @$S(ONCOED=6:"PHA6",ONCOED=5:"PHA5",ONCOED>2:"PHA34^ONCSG0",1:"PHA12^ONCSG0")
|
---|
12 | Q
|
---|
13 | ;
|
---|
14 | PHA5 ;Pharynx - 5th edition
|
---|
15 | I SP=67110 D PHAN56^ONCSG0 Q ;C11.0 Superior wall of nasopharynx
|
---|
16 | E D PHAOH5^ONCSG0 Q
|
---|
17 | ;
|
---|
18 | PHA6 ;Pharynx - 6th edition
|
---|
19 | I SP=67110 D PHAN56^ONCSG0 Q ;C11.0 Superior wall of nasopharynx
|
---|
20 | E D PHAOH6^ONCSG0 Q
|
---|
21 | ;
|
---|
22 | 5 ;Larynx
|
---|
23 | D @$S(ONCOED=6:"LAR6^ONCSG0",ONCOED=5:"LAR5^ONCSG0",ONCOED>2:"LAR34^ONCSG0",1:"LAR12^ONCSG0")
|
---|
24 | Q
|
---|
25 | ;
|
---|
26 | 6 ;Nasal Cavity and Paranasal Sinuses
|
---|
27 | D @$S(ONCOED=6:"PAR6^ONCSG0A",5:"PAR5^ONCSG0A",ONCOED>2:"PAR34^ONCSG0A",1:"PAR12^ONCSG0A")
|
---|
28 | Q
|
---|
29 | ;
|
---|
30 | 7 ;Major Salivary Glands
|
---|
31 | D @$S(ONCOED=6:"SAL6^ONCSG0A",ONCOED=5:"SAL5^ONCSG0A",ONCOED>2:"SAL34^ONCSG0A",1:"SAL12^ONCSG0A")
|
---|
32 | Q
|
---|
33 | ;
|
---|
34 | 8 ;Thyroid
|
---|
35 | D @$S(ONCOED=6:"THY6^ONCSG0A",1:"THY15^ONCSG0A")
|
---|
36 | Q
|
---|
37 | ;
|
---|
38 | PART3 ;DIGESTIVE SYSTEM
|
---|
39 | ;
|
---|
40 | 9 ;Esophogus
|
---|
41 | D @$S(ONCOED>4:"ESO56^ONCSG1",1:"ESO1234^ONCSG1")
|
---|
42 | Q
|
---|
43 | ;
|
---|
44 | 10 ;Stomach
|
---|
45 | D @$S(ONCOED=6:"STO6^ONCSG1",ONCOED=5:"STO5^ONCSG1",1:"STO34^ONCSG1")
|
---|
46 | Q
|
---|
47 | ;
|
---|
48 | 1 ;Small Intestine
|
---|
49 | I ONCOED<4 D Q
|
---|
50 | .W !!?12,"NO AJCC TNM Coding Schema for this edition."
|
---|
51 | .S SG=88
|
---|
52 | D SI^ONCSG1
|
---|
53 | Q
|
---|
54 | ;
|
---|
55 | 11 ;Colon and Rectum
|
---|
56 | D @$S(ONCOED=6:"COL6^ONCSG1",ONCOED=5:"COL5^ONCSG1",1:"COL34^ONCSG1")
|
---|
57 | Q
|
---|
58 | ;
|
---|
59 | 12 ;Anal Canal
|
---|
60 | D AC^ONCSG1
|
---|
61 | Q
|
---|
62 | ;
|
---|
63 | 13 ;Liver
|
---|
64 | D @$S(ONCOED=6:"LIV6^ONCSG1A",ONCOED=5:"LIV5^ONCSG1A",1:"LIV34^ONCSG1A")
|
---|
65 | Q
|
---|
66 | ;
|
---|
67 | 14 ;Gallbladder
|
---|
68 | D @$S(ONCOED=6:"GB6^ONCSG1A",ONCOED=5:"GB45^ONCSG1A",ONCOED=4:"GB45^ONCSG1A",1:"GB3^ONCSG1A")
|
---|
69 | Q
|
---|
70 | ;
|
---|
71 | 15 ;Extrahepatic Bile Ducts
|
---|
72 | D @$S(ONCOED=6:"EBD6^ONCSG1A",ONCOED>3:"EBD45^ONCSG1A",1:"EBD3^ONCSG1A")
|
---|
73 | Q
|
---|
74 | ;
|
---|
75 | 16 ;Ampulla of Vater
|
---|
76 | D @$S(ONCOED=6:"AV6^ONCSG1A",1:"AV345^ONCSG1A")
|
---|
77 | Q
|
---|
78 | ;
|
---|
79 | 17 ;Exocrine Pancreas
|
---|
80 | D @$S(ONCOED=6:"EXO6^ONCSG1A",ONCOED=5:"EXO5^ONCSG1A",1:"EXO34^ONCSG1A")
|
---|
81 | Q
|
---|
82 | ;
|
---|
83 | PART4 ;THORAX
|
---|
84 | ;
|
---|
85 | 18 ;Lung
|
---|
86 | D @$S(ONCOED>4:"LUN56^ONCSG2",1:"LUN34^ONCSG2")
|
---|
87 | Q
|
---|
88 | ;
|
---|
89 | 2 ;Pleural Mesothelioma
|
---|
90 | D @$S(ONCOED=6:"PM6^ONCSG2",1:"PM45^ONCSG2")
|
---|
91 | Q
|
---|
92 | ;
|
---|
93 | PART5 ;MUSCULOSKELETAL SITES
|
---|
94 | ;
|
---|
95 | 19 ;Bone
|
---|
96 | D @$S(ONCOED=6:"BONE6^ONCSG2",1:"BONE345^ONCSG2")
|
---|
97 | Q
|
---|
98 | ;
|
---|
99 | 20 ;Soft Tissue Sarcoma
|
---|
100 | D @$S(ONCOED=6:"STS6^ONCSG2",ONCOED=5:"STS5^ONCSG2",1:"STS34^ONCSG2")
|
---|
101 | Q
|
---|
102 | ;
|
---|
103 | PART6 ;SKIN
|
---|
104 | ;
|
---|
105 | 21 ;Carcinoma of the Skin
|
---|
106 | D CS^ONCSG3
|
---|
107 | Q
|
---|
108 | ;
|
---|
109 | 22 ;Melanoma of the Skin
|
---|
110 | D @$S(ONCOED=6:"MMS6^ONCSG3",ONCOED=5:"MMS5^ONCSG3",ONCOED=4:"MMS4^ONCSG3",1:"MMS3^ONCSG3")
|
---|
111 | Q
|
---|
112 | ;
|
---|
113 | PART7 ;BREAST
|
---|
114 | ;
|
---|
115 | 23 ;Breast
|
---|
116 | D @$S(ONCOED=6:"BRST6^ONCSG3",1:"BRST345^ONCSG3")
|
---|
117 | Q
|
---|
118 | ;
|
---|
119 | PART8 ;GYNECOLOGIC SITES
|
---|
120 | ;
|
---|
121 | 28 ;Vulva
|
---|
122 | D @$S(ONCOED>4:"VU56^ONCSG4",ONCOED=4:"VU4^ONCSG4",1:"VU3^ONCSG4")
|
---|
123 | Q
|
---|
124 | ;
|
---|
125 | 27 ;Vagina
|
---|
126 | D @$S(ONCOED>4:"VA56^ONCSG4",1:"VA34^ONCSG4")
|
---|
127 | Q
|
---|
128 | ;
|
---|
129 | 24 ;Cervix Uteri
|
---|
130 | D @$S(ONCOED>4:"CEU56^ONCSG4",1:"CEU34^ONCSG4")
|
---|
131 | Q
|
---|
132 | ;
|
---|
133 | 25 ;Corpus Uteri
|
---|
134 | D @$S(ONCOED=6:"COU6^ONCSG4",ONCOED>3:"COU45^ONCSG4",1:"COU3^ONCSG4")
|
---|
135 | Q
|
---|
136 | ;
|
---|
137 | 26 ;Ovary
|
---|
138 | D @$S(ONCOED=6:"OVA6^ONCSG4A",1:"OVA345^ONCSG4A")
|
---|
139 | Q
|
---|
140 | ;
|
---|
141 | 53 ;Fallopian Tube
|
---|
142 | D @$S(ONCOED=6:"FT6^ONCSG4A",1:"FT5^ONCSG4A")
|
---|
143 | Q
|
---|
144 | ;
|
---|
145 | 54 ;Gestational Trophoblastic Tumors
|
---|
146 | D @$S(ONCOED=6:"GTT6^ONCSG4A",1:"GTT5^ONCSG4A")
|
---|
147 | Q
|
---|
148 | ;
|
---|
149 | PART9 ;GENITOURINARY SITES
|
---|
150 | ;
|
---|
151 | 31 ;Penis
|
---|
152 | D PENIS^ONCSG5
|
---|
153 | Q
|
---|
154 | ;
|
---|
155 | 29 ;Prostate
|
---|
156 | D @$S(ONCOED>4:"PROS56^ONCSG5",ONCOED=4:"PROS4^ONCSG5",1:"PROS3^ONCSG5")
|
---|
157 | Q
|
---|
158 | ;
|
---|
159 | 30 ;Testis
|
---|
160 | D @$S(ONCOED>4:"TES56^ONCSG5",ONCOED=4:"TES4^ONCSG5",1:"TES3^ONCSG5")
|
---|
161 | Q
|
---|
162 | ;
|
---|
163 | 33 ;Kidney
|
---|
164 | D @$S(ONCOED=6:"KID6^ONCSG5",ONCOED=5:"KID5^ONCSG5",1:"KID34^ONCSG5")
|
---|
165 | Q
|
---|
166 | ;
|
---|
167 | 34 ;Renal Pelvis and Ureter
|
---|
168 | D @$S(ONCOED>3:"RPU456^ONCSG5A",1:"RPU3^ONCSG5A")
|
---|
169 | Q
|
---|
170 | ;
|
---|
171 | 32 ;Urinary Bladder
|
---|
172 | D @$S(ONCOED>4:"UB56^ONCSG5A",ONCOED=4:"UB4^ONCSG5A",1:"UB3^ONCSG5A")
|
---|
173 | Q
|
---|
174 | ;
|
---|
175 | 35 ;Urethra
|
---|
176 | D @$S(ONCOED>4:"U56^ONCSG5A",ONCOED=4:"U4^ONCSG5A",1:"U3^ONCSG5A")
|
---|
177 | Q
|
---|
178 | ;
|
---|
179 | PART10 ;OPHTHALMIC SITES
|
---|
180 | ;
|
---|
181 | 36 ;Carcinoma of the Eyelid
|
---|
182 | W !!?12,"No stage grouping is presently recommended."
|
---|
183 | S SG=88 Q
|
---|
184 | ;
|
---|
185 | 37 ;Malignant Melanoma of the Eyelid
|
---|
186 | I STGIND="C" D Q
|
---|
187 | .W !!?12,"No stage grouping is presently recommended."
|
---|
188 | .S SG=88
|
---|
189 | D MME34^ONCSG5A
|
---|
190 | Q
|
---|
191 | ;
|
---|
192 | 38 ;Carcinoma of the Conjunctiva
|
---|
193 | W !!?12,"No stage grouping is presently recommended."
|
---|
194 | S SG=88 Q
|
---|
195 | ;
|
---|
196 | 39 ;Malignant Melanoma of the Conjunctiva
|
---|
197 | W !!?12,"No stage grouping is presently recommended."
|
---|
198 | S SG=88 Q
|
---|
199 | ;
|
---|
200 | 40 ;Malignant Melanoma of the uvea
|
---|
201 | I TX=67693 D @$S(ONCOED=6:"MMU6^ONCSG5A",1:"CHO345^ONCSG5A") Q
|
---|
202 | I TX=67694 D @$S(ONCOED=6:"MMU6^ONCSG5A",1:"CBI345^ONCSG5A") Q
|
---|
203 | Q
|
---|
204 | ;
|
---|
205 | 41 ;Retinoblastoma
|
---|
206 | I ONCOED=6 D Q
|
---|
207 | .W !!?12,"No stage grouping applies."
|
---|
208 | .S SG=88
|
---|
209 | D RET345^ONCSG5A
|
---|
210 | Q
|
---|
211 | ;
|
---|
212 | 43 ;Carcinoma of the Lacrimal Gland
|
---|
213 | W !!?12,"No stage grouping is presently recommended."
|
---|
214 | S SG=88 Q
|
---|
215 | ;
|
---|
216 | 42 ;Sarcoma of the orbit
|
---|
217 | W !!?12,"No stage grouping is presently recommended."
|
---|
218 | S SG=88 Q
|
---|
219 | ;
|
---|
220 | PART11 ;CENTRAL NERVOUS SYSTEM
|
---|
221 | ;
|
---|
222 | 44 ;Brain and Spinal Cord
|
---|
223 | D BSC34^ONCSG5A
|
---|
224 | Q
|
---|
225 | ;
|
---|
226 | PART12 ;LYMPHOID NEOPLASMS
|
---|
227 | ;
|
---|
228 | 55 ;Mycosis fungoides
|
---|
229 | D MF6^ONCSG5A
|
---|
230 | Q
|
---|